| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2K | — | -78.0% |
| Cost of Revenue | $2K | +0.0% | -97.4% |
| Gross Profit | $49K | +2550.0% | +172.4% |
| R&D Expense | $52K | +477.8% | -57.5% |
| SG&A Expense | $1.2M | -55.3% | -4.2% |
| Operating Income | -$1.3M | +53.2% | +14.4% |
| Net Income | $429K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.0M | +92.6% | +119.8% |
| Short-term Investments | $240K | -11.4% | — |
| Accounts Receivable | $2K | -99.0% | -98.7% |
| Inventory | $16K | +0.0% | -68.6% |
| Current Assets | $8.7M | +72.6% | +156.8% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.3M | — | — |
| Investing Cash Flow | -$1.9M | — | — |
| Financing Cash Flow | $8.1M | — | — |
| +119.0% |
| EPS (Basic) | $0.45 | +350.0% | +215.4% |
| EPS (Diluted) | $0.97 | +638.9% | +348.7% |
| $11.0M |
| +42.2% |
| +89.4% |
| Current Liabilities | $2.1M | +94.2% | +297.7% |
| Total Liabilities | $2.4M | +6.8% | +353.0% |
| Stockholders' Equity | $8.9M | +54.9% | +64.1% |